Jean-Jacques Kiladjian/LinkedIn
Nov 24, 2025, 10:25
Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared on LinkedIn:
”A busy day visiting the INSERM-supervised CIC 1408 clinical investigation center in Saint-Etienne during its evaluation by HCERES, showcasing its dynamism and impressive scientific output in clinical pharmacology and public health, with a strong focus on vascular/hemostasis, immunomonitoring, inflammatory diseases (IBD and systemic), vaccinology, population health, paramedical research, and mental health.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 15:38Wolfgang Miesbach: How Haemophilia Care Has Evolved in China
-
May 27, 2026, 15:27Saja Abo Thyab: How MDS Can Progress to AML
-
May 27, 2026, 15:25Ifeanyichukwu Ifechidere: Coagulation Detective Case – The Prolonged APTT Mystery
-
May 27, 2026, 15:23Rushikesh Raut: Understanding Pancytopenia in Medical Coding
-
May 27, 2026, 15:19Dip Ghosh: Understanding Blood – From Sample to Diagnosis
-
May 27, 2026, 15:14Jeremiah Bernier-Latmani: Could Angpt2 Blockade Become a New Treatment for GI Bleeding in VWD
-
May 27, 2026, 15:11Paolo Zamboni: How Female Steroid Metabolism Triggers Lipedema?
-
May 27, 2026, 14:56Veronica Sanchez: Risk Factors and How to Recognize the Signs of Preeclampsia
-
May 27, 2026, 14:45Suvro Sankha Datta: New Frontiers in Platelet Transfusion and Preservation